StonvexLoading…
StonvexStonvexStonvexCore line items from QLYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $175.64M | $669.13M | $493.84M | $323.96M |
Operating Income | $60.88M | $221.95M | $163.12M | $103.16M |
Net Income | $50.64M | $198.32M | $145.17M | $47.29M |
EPS (Diluted) | $1.42 | $5.44 | $3.97 | $2.59 |
Total Assets | $1.09B | $1.10B | $1.03B | $999.50M |
Total Liabilities | $524.76M | $533.93M | $502.59M | $491.34M |
Cash & Equivalents | $279.47M | $250.26M | $225.25M | $193.98M |
Free Cash Flow OCF − CapEx | $93.63M | $304.41M | $229.47M | $139.99M |
Shares Outstanding | 35.38M | 35.73M | 35.91M | 36.13M |